Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cbi.2020.109298 http://scihub22266oqcxt.onion/10.1016/j.cbi.2020.109298 33121920!7588316!33121920     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33121920&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Chem+Biol+Interact 2020 ; 332 (?): 109298 Nephropedia Template TP {{tp|p=33121920|t=2020. Race to arsenal COVID-19 therapeutics: Current alarming status and future directions |pdf=|usr=}}{{33121920}} gab.com Text Race to arsenal COVID-19 therapeutics: Current alarming status and future directions JO: Chem Biol Interact http://www.kidney.de/pget.php?&tw=1&pmid=33121920 #FOAvip The on-going pandemic of COVID-19 wreaked by a viral infection of SARS-CoV-2, has generated a catastrophic plight across the globe. Interestingly, one of the hallmarks of COVID-19 is the so-called 'cytokine storm' due to attack of SARS-Cov-2 in the lungs. Considering, mesenchymal stem cells (MSCs) therapy could contribute against SARS-CoV-2 viruses attack because of their immune modulatory and anti-inflammatory ability linked to their stemness, to the arsenal of treatments for COVID-19. Another novel therapeutic strategies include the blockade of rampant generation of pro-inflammatory mediators like acute respiratory distress syndrome (ARDS), degradation of viral protein capsids by PROTACs, composed of Ubiquitin-proteasome framework, and ubiquitination-independent pathway directing the SARS-CoV-2 nucleocapsid protein (nCoV N) and proteasome activator (PA28gamma), etc. This review is consequently an endeavour to highlight the several aspects of COVID-19 with incorporation of important treatment strategies discovered to date and putting the real effort on the future directions to put them into the perspective. Twit Text FOAVip Race to arsenal COVID-19 therapeutics: Current alarming status and future directions ????Chem Biol Interact http://www.kidney.de/pget.php?&tw=1&pmid=33121920 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33121920 #FOAvip English Wikipedia <ref>{{Cite pmid|33121920}}</ref> Race to arsenal COVID-19 therapeutics: Current alarming status and future directions #MMPMID33121920 Dubey AK; Singh A; Prakash S; Kumar M; Singh AK Chem Biol Interact 2020[Dec]; 332 (?): 109298 PMID33121920show ga The on-going pandemic of COVID-19 wreaked by a viral infection of SARS-CoV-2, has generated a catastrophic plight across the globe. Interestingly, one of the hallmarks of COVID-19 is the so-called 'cytokine storm' due to attack of SARS-Cov-2 in the lungs. Considering, mesenchymal stem cells (MSCs) therapy could contribute against SARS-CoV-2 viruses attack because of their immune modulatory and anti-inflammatory ability linked to their stemness, to the arsenal of treatments for COVID-19. Another novel therapeutic strategies include the blockade of rampant generation of pro-inflammatory mediators like acute respiratory distress syndrome (ARDS), degradation of viral protein capsids by PROTACs, composed of Ubiquitin-proteasome framework, and ubiquitination-independent pathway directing the SARS-CoV-2 nucleocapsid protein (nCoV N) and proteasome activator (PA28gamma), etc. This review is consequently an endeavour to highlight the several aspects of COVID-19 with incorporation of important treatment strategies discovered to date and putting the real effort on the future directions to put them into the perspective. |*COVID-19 Drug Treatment[MESH] |Animals[MESH] |COVID-19/epidemiology/etiology/therapy[MESH] |Humans[MESH] |Pandemics[MESH]Race to arsenal COVID-19 therapeutics: Current alarming status and fut(epmc).pdf DeepDyve Pubget Overpricing